News | Pediatric Imaging | November 29, 2023

The findings show promise for an objective method of diagnosis of the condition affecting 5.7 million children and adolescents in the U.S.

Child undergoing pediatric MRI. (Courtesy of RadiologyInfo.org)

November 29, 2023 — Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and without attention-deficit/hyperactivity disorder (ADHD), researchers found significant differences in nine brain white matter tracts in individuals with ADHD. Results of the study will be presented today at the annual meeting of the Radiological Society of North America (RSNA).

Justin Huynh, M.S.

Justin Huynh, M.S.

ADHD is a common disorder often diagnosed in childhood and continuing into adulthood, according to the Centers for Disease Control and Prevention. In the U.S., an estimated 5.7 million children and adolescents between the ages of 6 and 17 have been diagnosed with ADHD.

“ADHD often manifests at an early age and can have a massive impact on someone’s quality of life and ability to function in society,” said study co-author Justin Huynh, M.S., a research specialist in the Department of Neuroradiology at the University of California, San Francisco, and medical student at the Carle Illinois College of Medicine at Urbana-Champaign. “It is also becoming increasingly prevalent in society among today’s youth, with the influx of smartphones and other distracting devices readily accessible.”

Children with ADHD may have trouble paying attention, controlling impulsive behaviors or regulating activity. Early diagnosis and intervention are key to managing the condition.

“ADHD is extremely difficult to diagnose and relies on subjective self-reported surveys,” Huynh said. “There is definitely an unmet need for more objective metrics for diagnosis. That’s the gap we are trying to fill.”

Huynh said this is the first study to apply deep learning, a type of AI, to identify markers of ADHD in the multi-institutional Adolescent Brain Cognitive Development (ABCD) Study, which includes brain imaging, clinical surveys and other data on over 11,000 adolescents from 21 research sites in the U.S. The brain imaging data included a specialized type of MRI called diffusion-weighted imaging (DWI).

“Prior research studies using AI to detect ADHD have not been successful due to a small sample size and the complexity of the disorder,” Huynh said.

The research team selected a group of 1,704 individuals from the ABCD dataset, including adolescents with and without ADHD. Using DWI scans, the researchers extracted fractional anisotropy (FA) measurements along 30 major white matter tracts in the brain. FA is a measure of how water molecules move along the fibers of white matter tracts.

The FA values from 1,371 individuals were used as input for training a deep-learning AI model, which was then tested on 333 patients, including 193 diagnosed with ADHD and 140 without. ADHD diagnoses were determined by the Brief Problem Monitor assessment, a rating tool used for monitoring a child’s functioning and their responses to interventions.

With the help of AI, the researchers discovered that in patients with ADHD, FA values were significantly elevated in nine white matter tracts.

“These differences in MRI signatures in individuals with ADHD have never been seen before at this level of detail,” Huynh said. “In general, the abnormalities seen in the nine white matter tracts coincide with the symptoms of ADHD.”

The researchers intend to continue obtaining data from the rest of the individuals in the ABCD dataset, comparing the performance of additional AI models.

“Many people feel that they have ADHD, but it is undiagnosed due to the subjective nature of the available diagnostic tests,” Huynh said. “This method provides a promising step towards finding imaging biomarkers that can be used to diagnose ADHD in a quantitative, objective diagnostic framework,” Huynh said.

Co-authors are Pierre F. Nedelec, M.S., M.T.M., Samuel Lashof-Regas, Michael Romano, M.D., Ph.D., Leo P. Sugrue, M.D., Ph.D., and Andreas M. Rauschecker, M.D., Ph.D.

For more information: www.rsna.org

Find more RSNA23 conference coverage here

 

Related content: 

Researchers Use MRI to Show Brain Changes, Differences in Children with ADHD 

Artificial Intelligence Boosts MRI Detection of ADHD 

ADHD Medication May Affect Brain Development in Children 

MRI Shows Brain Differences Among ADHD Patients 


Related Content

News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | X-Ray

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an ...

Time July 14, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
Subscribe Now